YTHDF2 and central nervous system cancer: A single-cell study of 3321 cells from six patients with glioma demonstrated that YTHDF2 was overexpressed in malignant glioma cells and monocytes/macrophages in the TME (GSE102130, Supplementary Figure S1D).